Systematic testing for venous thromboembolism in hospitalized patients with COVID-19 and raised D-dimer levels
Weinberg, Ido (Massachusetts General Hospital (Boston, Estats Units d'Amèrica))
Fernández-Capitán, Carmen (Hospital Universitario La Paz (Madrid))
Quintana Diaz, Manuel (Hospital Universitario La Paz (Madrid))
Demelo-Rodriguez, Pablo (Hospital General Universitario Gregorio Marañón)
García de Casasola, Gonzalo (Hospital IFEMA (Madrid))
Fidalgo, Ángeles (Hospital Clínico Universitario (Salamanca))
Maria Suriñach, Josep (Hospital Universitari Vall d'Hebron)
Díaz-Pedroche, Carmen (Hospital 12 de Octubre (Madrid))
Galeano-Valle, Francisco (University Hospital of Parma (Parma, Itàlia))
Siniscalchi, Carmine (Azienda Ospedaliera Universitaria Parma)
Visonà, Adriana (Ospedale Castelfranco)
Bikdeli, Behnood (Brigham and Women's Hospital (Boston, Estats Units d'Amèrica))
Jiménez, David (Hospital Universitario Ramón y Cajal (Madrid))
Monreal Bosch, Manuel (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol)

Date:	2021
Abstract:	Hospitalized patients with COVID-19 and raised D-dimer levels have high rates of venous thromboembolism (VTE). We used data from hospitalized patients with COVID-19 that were tested for pulmonary embolism (PE) or deep vein thrombosis (DVT) because of raised D-dimer levels. We aimed to identify patients at increased risk for VTE. From March 25 to July 5th, 2020, 1,306 hospitalized patients with COVID-19 and raised D-dimer levels underwent testing for VTE in 12 centers. In all, 171 of 714 (24%) had PE, and 161 of 810 (20%) had DVT. The median time elapsed from admission to VTE testing was 12 days, and the median time from D-dimer measurement to testing 2 days. Most patients with VTE were men (62%), mean age was 62 ​± ​15 years, 45% were in an intensive care unit. Overall, 681 patients (52%) received VTE prophylaxis with standard doses, 241 (18%) with intermediate doses and 100 (7. 7%) with therapeutic doses of anticoagulants. On multivariable analysis, patients with D-dimer levels.
Rights:	Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, i la comunicació pública de l'obra, sempre que no sigui amb finalitats comercials, i sempre que es reconegui l'autoria de l'obra original. No es permet la creació d'obres derivades.
Language:	Anglès
Document:	Article ; recerca ; Versió publicada
Published in:	Thrombosis Update, Vol. 2 (march 2021) , p. 100029, ISSN 2666-5727

DOI: 10.1016/j.tru.2020.100029
PMID: 38620598

6 p, 455.9 KB

The record appears in these collections:
Research literature > UAB research groups literature > Research Centres and Groups (research output) > Health sciences and biosciences > Institut d'Investigació en Ciencies de la Salut Germans Trias i Pujol (IGTP)
Articles > Research articles
Articles > Published articles